Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma of the Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03244384
What this trial is testing

Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

Who this might be right for
Localized Renal Pelvis and Ureter Urothelial CarcinomaLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis and Ureter Urothelial Carcinoma+8 more
National Cancer Institute (NCI) 739
Testing effectiveness (Phase 2)Study completedNCT02108652
What this trial is testing

Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)

Who this might be right for
Bladder Cancer
Hoffmann-La Roche 310
Not applicableWithdrawnNCT02514408
What this trial is testing

Circulating Tumor Cells in Operative Blood in Patients With Bladder Cancer

Who this might be right for
Stage II Bladder Urothelial Carcinoma
University of Southern California
Large-scale testing (Phase 3)Study completedNCT02632409
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 709
Not applicableUnknownNCT03796299
What this trial is testing

Expression of MCM5 in Urine in Patients With Urothelial Cancers

Who this might be right for
Bladder Cancer
Medical University of Warsaw 180
Not applicableUnknownNCT05077852
What this trial is testing

Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder

Who this might be right for
Bladder CancerBenign Prostatic HyperplasiaHematuria
Ankara Training and Research Hospital 194
Not applicableNot Yet RecruitingNCT07817173
What this trial is testing

Feasibility of HISA During TURBT for NMIBC

Who this might be right for
Bladder CancerBladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)Non-muscle Invasive Bladder Cancer (NMIBC)+6 more
CAMC Health System 40
Early research (Phase 1)Ended earlyNCT00072137
What this trial is testing

Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy

Who this might be right for
Bladder AdenocarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+5 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT05327530
What this trial is testing

The Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)

Who this might be right for
Locally Advanced or Metastatic Urothelial Carcinoma
EMD Serono Research & Development Institute, Inc. 256
Testing effectiveness (Phase 2)Ended earlyNCT00363883
What this trial is testing

Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium

Who this might be right for
Localized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+2 more
National Cancer Institute (NCI) 14
Large-scale testing (Phase 3)Ended earlyNCT01438112
What this trial is testing

Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer

Who this might be right for
Transitional Cell CarcinomaBladder CancerCarcinoma in Situ+1 more
CG Oncology, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT02438865
What this trial is testing

Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.

Who this might be right for
Neoplasm, UreterNeoplasm, Bladder
Mansoura University 74
Testing effectiveness (Phase 2)Study completedNCT01551030
What this trial is testing

Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Metastatic Transitional Cell Carcinoma of the Urothelium
Memorial Sloan Kettering Cancer Center 19
Not applicableUnknownNCT05027412
What this trial is testing

En Bloc TURBT With Collins Loop vs Conventional TURBT

Who this might be right for
Bladder CancerBladder NeoplasmBladder Urothelial Carcinoma+2 more
Hospital Universitario de Fuenlabrada 80
Not applicableUnknownNCT06564363
What this trial is testing

The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Wuhan Ammunition Life-tech Co., Ltd 148
Large-scale testing (Phase 3)Study completedNCT01442519
What this trial is testing

Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
University of Rome Tor Vergata 212
Not applicableActive Not RecruitingNCT05080998
What this trial is testing

Longitudinal Bladder Cancer Study for Tumour Recurrence

Who this might be right for
Urothelial Bladder Cancer
Pacific Edge Limited 450
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Testing effectiveness (Phase 2)Active Not RecruitingNCT03317158
What this trial is testing

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Urothelial CarcinomaBladder Cancer
Noah Hahn, M.D. 186
Testing effectiveness (Phase 2)UnknownNCT03113266
What this trial is testing

Safety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma

Who this might be right for
Bladder Urothelial Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 370
Next Page